Clackson T, Ultsch M H, Wells J A, de Vos A M
Department of Protein Engineering, Genentech, Inc., 460 Point San Bruno Blvd., South San Francisco, CA 94080, USA.
J Mol Biol. 1998 Apr 17;277(5):1111-28. doi: 10.1006/jmbi.1998.1669.
The designed G120R mutant of human growth hormone (hGH) is an antagonist and can bind only one molecule of the growth hormone receptor. We have determined the crystal structure of the 1:1 complex between this mutant and the receptor extracellular domain (hGHbp) at 2.6 A resolution, and used it to guide a detailed survey of the structural and functional basis for hormone-receptor recognition. The overall structure of the complex is very similar to the equivalent portion of the 1:2 complex, showing that formation of the active complex does not involve major conformational changes. However, a segment involved in receptor-receptor interactions in the 1:2 complex is disordered in this structure, suggesting that its productive conformation is stabilized by receptor dimerization. The hormone binding site of the receptor comprises a central hydrophobic patch dominated by Trp104 and Trp169, surrounded by a hydrophilic periphery containing several well-ordered water molecules. Previous alanine scanning showed that the hydrophobic "hot spot" confers most of the binding energy. The new structural data, coupled with binding and kinetic analysis of further mutants, indicate that the hot spot is assembled cooperatively and that many residues contribute indirectly to binding. Several hydrophobic residues serve to orient the key tryptophan residues; kinetic analysis suggests that Pro106 locks the Trp104 main-chain into a required conformation. The electrostatic contacts of Arg43 to hGH are less important than the intramolecular packing of its alkyl chain with Trp169. The true functional epitope that directly contributes binding energy may therefore comprise as few as six side-chains, participating mostly in alkyl-aromatic stacking interactions. Outside the functional epitope, multiple mutation of residues to alanine resulted in non-additive increases in affinity: up to tenfold for a hepta-alanine mutant. Contacts in the epitope periphery can therefore attenuate the affinity of the central hot spot, perhaps reflecting a role in conferring specificity to the interaction.
设计的人生长激素(hGH)G120R突变体是一种拮抗剂,仅能结合一个生长激素受体分子。我们已确定该突变体与受体细胞外结构域(hGHbp)之间1:1复合物的晶体结构,分辨率为2.6埃,并以此指导对激素 - 受体识别的结构和功能基础进行详细研究。该复合物的整体结构与1:2复合物的相应部分非常相似,表明活性复合物的形成不涉及主要的构象变化。然而,在1:2复合物中参与受体 - 受体相互作用的一个片段在该结构中是无序的,这表明其有效构象通过受体二聚化得以稳定。受体的激素结合位点包括一个以Trp104和Trp169为主的中央疏水区域,周围是含有几个排列有序水分子的亲水性周边区域。先前的丙氨酸扫描表明,疏水“热点”赋予了大部分结合能。新的结构数据,结合对其他突变体的结合和动力学分析,表明热点是协同组装的,许多残基间接有助于结合。几个疏水残基用于定位关键的色氨酸残基;动力学分析表明Pro106将Trp104主链锁定在所需构象中。Arg43与hGH的静电接触不如其烷基链与Trp169的分子内堆积重要。因此,直接贡献结合能的真正功能表位可能仅由六个侧链组成,主要参与烷基 - 芳族堆积相互作用。在功能表位之外,将残基多突变为丙氨酸导致亲和力非加性增加:七丙氨酸突变体高达十倍。因此,表位周边的接触可以减弱中央热点的亲和力,这可能反映了在赋予相互作用特异性方面的作用。